After implantation, patients are able to return home with the therapy activated; no daily interventions or manual adjustments are required. The Food and Drug Administration (FDA) has cleared Medtronic ...

UAB delivers its first implantable tibial neuromodulation therapy for urge urinary incontinence, expanding durable, minimally ...

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...

Study findings show postoperative setting, urinary catheter insertion and use of an implantable device could be risk factors for surgical site infection among children, according to research published ...

BlueWind plans to use the funds for expanding sales functions and market access initiatives for its Revi implantable tibial neuromodulation system.

Please provide your email address to receive an email when new articles are posted on . The device significantly improved quality of life and symptoms among women with urgency urinary incontinence ...

The US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for treating urinary urge incontinence (UUI). The California-based company’s ...

PARK CITY, Utah--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and developer of the Revi® System, a patient-centric solution for urge urinary ...

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire ...